[EN] NOVEL SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS [FR] NOUVEAUX COMPOSÉS AROMATIQUES BICYCLIQUES SUBSTITUÉS EN TANT QU'INHIBITEURS DE LA S-NITROSOGLUTATHION RÉDUCTASE
[EN] NOVEL SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS [FR] NOUVEAUX COMPOSÉS AROMATIQUES BICYCLIQUES SUBSTITUÉS EN TANT QU'INHIBITEURS DE LA S-NITROSOGLUTATHION RÉDUCTASE
Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors
申请人:Sun Xicheng
公开号:US20130178499A1
公开(公告)日:2013-07-11
The present invention is directed to novel quinoline compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.
Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
申请人:Sun Xicheng
公开号:US20130261123A1
公开(公告)日:2013-10-03
The present invention is directed to novel substituted bicyclic aromatic compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.
Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
申请人:Sun Xicheng
公开号:US08921562B2
公开(公告)日:2014-12-30
The present invention is directed to novel quinoline compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.
Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors
申请人:Nivalis Therapeutics, Inc.
公开号:US09364481B2
公开(公告)日:2016-06-14
The present invention is directed to novel substituted bicyclic aromatic compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.
[EN] NOVEL SUBSTITUTED QUINOLINE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS<br/>[FR] NOUVEAUX COMPOSÉS QUINOLÉINE SUBSTITUÉS EN TANT QU'INHIBITEURS DE S-NITROSOGLUTATHIONE RÉDUCTASE